Literature DB >> 33077937

Base editing: advances and therapeutic opportunities.

Elizabeth M Porto1, Alexis C Komor2, Ian M Slaymaker3, Gene W Yeo4,5,6.   

Abstract

Base editing - the introduction of single-nucleotide variants (SNVs) into DNA or RNA in living cells - is one of the most recent advances in the field of genome editing. As around half of known pathogenic genetic variants are due to SNVs, base editing holds great potential for the treatment of numerous genetic diseases, through either temporary RNA or permanent DNA base alterations. Recent advances in the specificity, efficiency, precision and delivery of DNA and RNA base editors are revealing exciting therapeutic opportunities for these technologies. We expect the correction of single point mutations will be a major focus of future precision medicine.

Entities:  

Mesh:

Year:  2020        PMID: 33077937      PMCID: PMC7721651          DOI: 10.1038/s41573-020-0084-6

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   112.288


  238 in total

Review 1.  Non-coding genetic variants in human disease.

Authors:  Feng Zhang; James R Lupski
Journal:  Hum Mol Genet       Date:  2015-07-07       Impact factor: 6.150

2.  Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.

Authors:  Giedrius Gasiunas; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  Genomic characterization of metastatic breast cancers.

Authors:  François Bertucci; Charlotte K Y Ng; Anne Patsouris; Thomas Filleron; Christophe Le Tourneau; Fabrice André; Nathalie Droin; Salvatore Piscuoglio; Nadine Carbuccia; Jean Charles Soria; Alicia Tran Dien; Yahia Adnani; Maud Kamal; Séverine Garnier; Guillaume Meurice; Marta Jimenez; Semih Dogan; Benjamin Verret; Max Chaffanet; Thomas Bachelot; Mario Campone; Claudia Lefeuvre; Herve Bonnefoi; Florence Dalenc; Alexandra Jacquet; Maria R De Filippo; Naveen Babbar; Daniel Birnbaum
Journal:  Nature       Date:  2019-05-22       Impact factor: 49.962

4.  Efficient and allele-specific genome editing of disease loci in human iPSCs.

Authors:  Cory Smith; Leire Abalde-Atristain; Chaoxia He; Brett R Brodsky; Evan M Braunstein; Pooja Chaudhari; Yoon-Young Jang; Linzhao Cheng; Zhaohui Ye
Journal:  Mol Ther       Date:  2014-11-24       Impact factor: 11.454

5.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

6.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

Review 7.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

Authors:  Alexis C Komor; Ahmed H Badran; David R Liu
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

8.  A general framework for estimating the relative pathogenicity of human genetic variants.

Authors:  Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

Review 9.  Single nucleotide variations: biological impact and theoretical interpretation.

Authors:  Panagiotis Katsonis; Amanda Koire; Stephen Joseph Wilson; Teng-Kuei Hsu; Rhonald C Lua; Angela Dawn Wilkins; Olivier Lichtarge
Journal:  Protein Sci       Date:  2014-10-20       Impact factor: 6.725

10.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

View more
  38 in total

1.  Adenine base-editing-mediated exon skipping induces gene knockout in cultured pig cells.

Authors:  Xiang-Xing Zhu; Jia-Sheng Pan; Tao Lin; Ye-Cheng Yang; Qiu-Yan Huang; Shuai-Peng Yang; Zi-Xiao Qu; Zi-Sheng Lin; Jian-Cong Wen; Ai-Fen Yan; Juan Feng; Lian Liu; Xiao-Li Zhang; Jia-Hong Lu; Dong-Sheng Tang
Journal:  Biotechnol Lett       Date:  2022-01-08       Impact factor: 2.461

2.  Targeting Alternative Splicing for Therapeutic Interventions.

Authors:  Jessica L Centa; Michelle L Hastings
Journal:  Methods Mol Biol       Date:  2022

3.  Hypercompact adenine base editors based on transposase B guided by engineered RNA.

Authors:  Do Yon Kim; Yuhee Chung; Yujin Lee; Dongmin Jeong; Kwang-Hyun Park; Hyun Jung Chin; Jeong Mi Lee; Seyeon Park; Sumin Ko; Jeong-Heon Ko; Yong-Sam Kim
Journal:  Nat Chem Biol       Date:  2022-08-01       Impact factor: 16.174

4.  High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Authors:  Huawei Tong; Jia Huang; Qingquan Xiao; Bingbing He; Xue Dong; Yuanhua Liu; Xiali Yang; Dingyi Han; Zikang Wang; Xuchen Wang; Wenqin Ying; Runze Zhang; Yu Wei; Chunlong Xu; Yingsi Zhou; Yanfei Li; Minqing Cai; Qifang Wang; Mingxing Xue; Guoling Li; Kailun Fang; Hainan Zhang; Hui Yang
Journal:  Nat Biotechnol       Date:  2022-08-11       Impact factor: 68.164

Review 5.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

Review 6.  Recent advances in CRISPR technologies for genome editing.

Authors:  Myeonghoon Song; Taeyoung Koo
Journal:  Arch Pharm Res       Date:  2021-06-23       Impact factor: 4.946

Review 7.  CRISPR-based genome editing through the lens of DNA repair.

Authors:  Tarun S Nambiar; Lou Baudrier; Pierre Billon; Alberto Ciccia
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

Review 8.  CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.

Authors:  Hanan Bloomer; Jennifer Khirallah; Yamin Li; Qiaobing Xu
Journal:  Adv Drug Deliv Rev       Date:  2021-12-20       Impact factor: 15.470

Review 9.  Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.

Authors:  Hongchao Guo; Lichao Liu; Masataka Nishiga; Le Cong; Joseph C Wu
Journal:  Trends Genet       Date:  2021-09-08       Impact factor: 11.639

Review 10.  The glomerular filtration barrier: a structural target for novel kidney therapies.

Authors:  Ilse S Daehn; Jeremy S Duffield
Journal:  Nat Rev Drug Discov       Date:  2021-07-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.